12:00 AM
 | 
Jul 26, 2004
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Alamo Pharmaceuticals, Cima sales and marketing update

Alamo launched its Fazaclo orally disintegrating formulation of clozapine to treat severe schizophrenia in patients who...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >